Literature DB >> 36034980

Erratum to SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway.

.   

Abstract

[This corrects the article DOI: 10.21037/atm-20-5984.]. 2022 Annals of Translational Medicine. All rights reserved.

Entities:  

Year:  2022        PMID: 36034980      PMCID: PMC9403932          DOI: 10.21037/atm-2022-12

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


In the article entitled “SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway” (1), GAPDH pictures mentioned below was misplaced and repeated incorrectly due to lack of picture editing of the article: (I) The GAPDH pictures of group H-1299 in Figures 2C, 4D and 5B were repeatedly used, which should be corrected as follows: Figure 4D in H-1299 group needs to be changed to: Figure 5B in H-1299 group needs to be changed to: (II) The GAPDH pictures of group H-520 in Figures 2D, 4D and 5B were repeatedly used and should be corrected as follows: Figure 4D in H-520 group needs to be changed to: Figure 5B in H-520 group needs to be changed to: The authors confirmed this error did not affect either the results or the conclusions of the paper. Click here to view the updated version of the article.
  1 in total

1.  SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway.

Authors:  Yan Feng; Xiangyu Guo; Huaping Tang
Journal:  Ann Transl Med       Date:  2021-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.